Company Monitoring Page for Janssen

latest headlines for company on cafepharma

New TREMFYA Data Show an Overall Clinical Response Rate of Approximately 80 Percent in a Phase 2b Induction Study of Adults with Moderately to Severely Active Ulcerative Colitis
Marketscreener
Tue, 10/25/22 - 10:53 am
Tags:
JNJ, Janssen, clinical trials, ulcerative colitis, Tremfya
Janssen Touts Positive Mid-Late Stage Data From Two Ulcerative Colitis Trials
BioSpace
Mon, 10/10/22 - 10:52 am
Tags:
JNJ, Janssen, ulcerative colitis, guselkumab, golimumab
Janssen reports Phase II data for Darzalex-RVd to treat multiple myeloma
Clinical Trials Arena
Mon, 08/29/22 - 10:32 am
Tags:
JNJ, Janssen, clinical trials, Darzalex, Revlimid, Velcade, Multiple Myeloma
Janssen secures FDA breakthrough designation for myeloma therapy
Pharmaceutical Business Review
Thu, 06/30/22 - 10:54 am
Tags:
JNJ, Janssen, breakthrough therapy, FDA, talquetamab, Multiple Myeloma, relapsed or refractory multiple myeloma
Janssen Recruiting for Phase III Trials of Potential Myasthenia Gravis Game Changer
BioSpace
Mon, 06/20/22 - 10:57 am
Tags:
Janssen, JNJ, clinical trials, nipocalimab, myasthenia gravis
Janssen's Imbruvica Demonstrates Significant Survival Outcomes In Older Lymphoma Patients
BioSpace
Mon, 06/6/22 - 10:03 am
Tags:
ASCO 2022, JNJ, Janssen, Imbruvica, clinical trials, lymphoma
ASCO: Is another pan-tumor drug on the horizon? Johnson & Johnson thinks Balversa could be it
Fierce Pharma
Fri, 05/27/22 - 10:19 am
Tags:
ASCO 2022, JNJ, Janssen, pan-tumor, Balversa
Janssen Presents New Data that could Set Anti-Inflammatory Drug Apart
BioSpace
Thu, 05/19/22 - 09:00 pm
Tags:
JNJ, Janssen, Tremfya, Skyrizi, AbbVie, anti-inflammatories
J&J ends hepatitis B and HPV portions of Bavarian Nordic collab
Endpoints
Mon, 05/9/22 - 10:33 am
Tags:
JNJ, Janssen, Bavarian Nordic, vaccines, hepatitis B, HPV
Illumina secures drug discovery tie-ups with Janssen, Deerfield
Biopharma Reporter
Mon, 05/9/22 - 10:11 am
Tags:
Illumina, Janssen, JNJ, Deerfield Management, drug discovery
J&J new social media series supports and celebrates ‘warrior’ nurses in pulmonary hypertension
Endpoints
Sun, 05/8/22 - 12:21 pm
Tags:
JNJ, Janssen, pulmonary hypertension, social media, nurses
With millions on the line, Alkermes, J&J start arbitration over drug delivery tech dispute
Fierce Pharma
Fri, 04/22/22 - 10:32 am
Tags:
Alkermes, JNJ, Janssen, drug delivery, Nanocrystal
Legend Biotech Achieves Milestone Under Collaboration Agreement with Janssen Biotech, Inc. for BCMA CAR-T
BioSpace
Thu, 04/21/22 - 10:57 am
Tags:
Legend Biotech, Janssen, Carvykti, cilta-cel, CAR-T
With competitors circling, ViiV wins another label update for long-acting HIV injectable Cabenuva
Endpoints
Thu, 03/24/22 - 08:33 pm
Tags:
ViiV Healthcare, GSK, FDA, Cabenuva, HIV, Janssen
J&J lands Tremfya one-two punch in IBD with first ulcerative colitis win and long-term Crohn's data
Fierce Pharma
Mon, 02/21/22 - 10:37 am
Tags:
JNJ, Janssen, Tremfya, Crohn's Disease
Remix Therapeutics signs Janssen licensing deal that could top $1B
Fierce Biotech
Thu, 02/17/22 - 10:53 am
Tags:
Remix Therapeutics, RNA, Janssen, JNJ, small molecule drugs
AC Immune's Janssen-partnered Alzheimer's vaccine spurs tau-attacking antibodies in early-stage trial
Fierce Biotech
Tue, 02/15/22 - 10:32 am
Tags:
AC Immune, Janssen, JNJ, vaccines, Alzheimer's disease, clinical trials
J&J's Blue Jacket Fashion Show returns live to boost prostate cancer awareness
Fierce Pharma
Tue, 02/15/22 - 10:29 am
Tags:
pharma marketing, JNJ, Janssen, oncology, prostate cancer
J&J's Janssen inks $1B biobucks pact for Mersana's ADC tech in 3 targets
Fierce Biotech
Thu, 02/3/22 - 11:18 am
Tags:
JNJ, Janssen, Mersana, antibody-drug conjugate, biobucks
J&J goes after another FDA approval for a cancer bispecific
Pharmaforum
Thu, 12/30/21 - 10:53 am
Tags:
JNJ, bispecific antibodies, cancer, FDA, Janssen, teclistamab, Multiple Myeloma

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.